HCA Holdings Inc (HCA)

HCA (NYSE:Health Services)
pos +0.88
Today's Range: 71.37 - 72.76 | HCA Avg Daily Volume: 3,343,600
Last Update: 09/18/14 - 4:00 PM EDT
Volume: 1,807,843
YTD Performance: 0.00%
Open: $71.77
Previous Close: $71.48
52 Week Range: $41.30 - $73.19
Oustanding Shares: 432,385,100
Market Cap: 31,002,011,670
6-Month Chart
TheStreet Ratings Grade for HCA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 13 13 13
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.21 1.22 1.22 1.22
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
HCA Sector Avg. S&P 500
0.00 20.30 28.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 3.50 0.11 0.04
Net Income -0.50 0.27 0.08
EPS -3.60 0.24 0.07
Earnings for HCA:
Revenue 34.18B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.97 $1.10 $4.21 $4.74
Number of Analysts 15 14 13 15
High Estimate $1.13 $1.33 $4.38 $5.26
Low Estimate $0.91 $1.01 $4.00 $4.34
Prior Year $0.79 $0.92 $3.41 $4.21
Growth Rate (Year over Year) 23.04% 19.25% 23.46% 12.54%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Sep 12, 2014 | 7:41 AM EDT
HCA was initiated with an Outperform rating, Leerink Partners said. $85 price target. Estimates are above consensus, as the company is ...
Yep, the bets for the rest of 2014 are being placed.

This Morning's Market Setup Real Money Pro($)

Where it began.
Unintended consequences of the law could benefit these operators.
In the short term, insurers and providers should continue to benefit from Obamacare.
Dec 18, 2013 | 7:50 AM EST
HCA was placed on the Conviction Buy list, according to Goldman Sachs. Company trades at a compelling valuation and has multiple potent...
Nov 06, 2013 | 8:27 AM EST
HCA estimates were raised through 2015, Bank of America/Merrill Lynch said. Company is seeing higher sales and margins. Buy rating and ...
Neither side is voting their interests.
Sep 18, 2013 | 7:01 AM EDT
HCA was upgraded from Neutral to Buy, Mizuho said. $51 price target. Company should benefit from healthcare reform.   
These stocks all pique my interest at current levels.

Columnist Conversations

FCEL closed trading at $2.24, down small with IV30™ up 8.1%. This is a follow up to a story I posted on ...
The chart of Delta looks very good and we have seen good option flow recently. This airline stands out among ...
mark mobius on market watch (dow jones) says buying baba is "not a good idea" due to his take on baba's corpor...
Mike Paulenoff's comments on Tarrget (TGT) prove once again how fast investor sentiment, and stock prices, can...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.